Plants as stable genetic carriers
How PlantPharm BioMed grows biopharmaceuticals inside plants and delivers them in oral solid dose form.
The world’s first oral solid dose Hepatitis B vaccine
PlantPharm BioMed’s process grew plants with the world’s first oral solid dose Hepatitis B vaccine, which was proven effective in a double-blind, placebo-based, FDA approved human trial. The ability to grow and deliver vaccines, and other biopharmaceuticals, using plants as the production medium has now become reality.
Solid oral delivery
Replaces hypodermic injection with a pill for humans or a pelletized feed dose for animals.
Low-cost & shelf-stable
Easy to ship without cold-chain infrastructure.
Highly scalable
Production scales with plant cultivation rather than industrial bioreactors.
Natural filtration
Naturally removes contaminants such as prions and viroids common to other biopharma manufacturing systems.
Stable replication
Genetically stable propagation eliminates production variability.
Mucosal delivery
Mucosal vaccinations are among the most effective delivery routes available.
The breakthrough
The ability to grow and deliver vaccines, and other biopharmaceuticals, using plants as the production medium has now become reality.PlantPharm BioMed, Ltd. — Technology overview
A platform compatible with hundreds of biopharmaceuticals
Beyond vaccines, PlantPharm’s manufacturing platform technology is deemed compatible with an estimated 500 additional biopharmaceutical drugs, suitable for production as monoclonal antibodies, therapeutic proteins, or peptides.